ResMed (RMD) Tops Q3 EPS by 20c
Tweet
Share
E-mail
Get Alerts RMD Hot Sheet
Price: $218.04 -0.87%
EPS Growth %: +5.5%
Financial Fact:
Income taxes (note 13): 16.82M
Today's EPS Names:
VIVO, BIOX, PMCB, More
EPS Growth %: +5.5%
Financial Fact:
Income taxes (note 13): 16.82M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
ResMed (NYSE: RMD) reported Q3 EPS of $2.13, $0.20 better than the analyst estimate of $1.93. Revenue for the quarter came in at $1.2 billion versus the consensus estimate of $1.17 billion.
For earnings history and earnings-related data on ResMed (RMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Monolithic Power Systems (MPWR) Reiterated at Buy by Stifel on Reaching $4B Target
- 1-800-FLOWERS.Com (FLWS) Misses Q4 EPS by 10c, Misses on Revenue; Offers Guidance
- Signet Jewelers (SIG) PT Raised to $136 at UBS on Strong Growth Prospects
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
